Shortly after speaking at The Deal's M&A Outlook 2008 conference at the Ritz-Carlton Battery Park in New York City, Carlyle Group co-founder David Rubenstein spoke with CNBC's Rebecca Jarvis. He spoke about some of the same issues that he discussed with The Deal's senior writer David Carey. — The editors
Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.
